DocGo Inc. (NASDAQ:DCGO - Get Free Report) has received a consensus rating of "Moderate Buy" from the six ratings firms that are presently covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $3.56.
A number of analysts recently weighed in on DCGO shares. Needham & Company LLC decreased their price target on shares of DocGo from $4.00 to $3.00 and set a "buy" rating for the company in a research report on Friday, May 9th. Stifel Nicolaus cut their price objective on shares of DocGo from $6.50 to $5.50 and set a "buy" rating on the stock in a report on Friday, February 28th. Canaccord Genuity Group reiterated a "hold" rating and issued a $1.45 price objective (down previously from $5.00) on shares of DocGo in a report on Monday, May 12th. Deutsche Bank Aktiengesellschaft lowered shares of DocGo from a "buy" rating to a "hold" rating and cut their price objective for the stock from $5.00 to $2.85 in a report on Friday, February 28th. Finally, BTIG Research lowered shares of DocGo from a "buy" rating to a "neutral" rating in a report on Friday, May 9th.
Check Out Our Latest Stock Report on DocGo
DocGo Stock Performance
DocGo stock traded up $0.07 during trading on Wednesday, reaching $1.47. 1,655,608 shares of the company's stock were exchanged, compared to its average volume of 790,893. The company's 50-day moving average is $2.37 and its two-hundred day moving average is $3.61. DocGo has a 52-week low of $1.35 and a 52-week high of $5.68. The firm has a market cap of $149.92 million, a price-to-earnings ratio of 5.25, a PEG ratio of 14.16 and a beta of 1.14.
DocGo (NASDAQ:DCGO - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported ($0.09) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.08). DocGo had a return on equity of 8.90% and a net margin of 4.35%. The business had revenue of $96.03 million for the quarter, compared to analysts' expectations of $104.25 million. Analysts anticipate that DocGo will post 0.25 EPS for the current year.
Institutional Investors Weigh In On DocGo
A number of institutional investors have recently modified their holdings of DCGO. Jefferies Financial Group Inc. raised its stake in shares of DocGo by 6,874.1% in the 1st quarter. Jefferies Financial Group Inc. now owns 2,029,456 shares of the company's stock valued at $5,358,000 after purchasing an additional 2,000,356 shares in the last quarter. WCM Investment Management LLC raised its stake in shares of DocGo by 64.2% in the 4th quarter. WCM Investment Management LLC now owns 4,314,071 shares of the company's stock valued at $18,637,000 after purchasing an additional 1,687,100 shares in the last quarter. American Century Companies Inc. raised its stake in shares of DocGo by 175.5% in the 1st quarter. American Century Companies Inc. now owns 1,245,894 shares of the company's stock valued at $3,289,000 after purchasing an additional 793,640 shares in the last quarter. S Squared Technology LLC raised its stake in shares of DocGo by 36.8% in the 1st quarter. S Squared Technology LLC now owns 1,890,976 shares of the company's stock valued at $4,992,000 after purchasing an additional 508,590 shares in the last quarter. Finally, P.A.W. Capital Corp raised its stake in shares of DocGo by 25.0% in the 1st quarter. P.A.W. Capital Corp now owns 2,000,000 shares of the company's stock valued at $5,280,000 after purchasing an additional 400,000 shares in the last quarter. Institutional investors and hedge funds own 56.44% of the company's stock.
About DocGo
(
Get Free ReportDocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Recommended Stories

Before you consider DocGo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.
While DocGo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.